TREM1 and pulmonary fibrosis: Interestingly, both GF9 and GA31-LPC were effective in preventing and treating BLM-induced pulmonary fibrosis (Figure 4B), suggesting that anti-inflammatory mechanisms of pan-TREM-1 and macrophage-restricted TREM-1 blockade may importantly contribute to the therapeutic effects in chronic inflammatory diseases.